REVIEW Sotalol hydrochloride is the salt of sotalol, a racemic phenethanolamine used in individuals with cardiac arrhythmias and to treat hypertension. It is a non-selective competitive beta-adrenergic receptor blocker that also exhibits Class III antiarrhythmic properties by its inhibition of potassium channels.
Uloth, Robert H.; Kirk, Jerry R.; Gould, William A.; Larsen, A. A. Sulfonanilides. I. Monoalkane- and arenesulfonamidophenethanolamines Journal of Medicinal Chemistry (1966), 9(1), 88-97.
Lish, P. M.; Weikel, J. H.; Dungan, K. W. Pharmacological and toxicological properties of two new β-adrenergic receptor antagonists Journal of Pharmacology and Experimental Therapeutics (1965), 149(2), 161-73.
Schnelle K Clinical pharmacology of adrenergic beta receptor blockade with sotalol (MJ 1999). Adv Clin Pharmacol. 1978;18:1-111.
Aviado DM.Sotalol, a pure beta-adrenergic blocking agent for treatment of essential hypertension and other cardiovascular diseases. J Clin Pharmacol. 1979 Aug-Sep;19(8-9 Pt 2):497-504.
These chemical products are for research and development use only. They are not for diagnostic, therapeutic, cosmetic, or human and animal uses. They are not sold to individuals. Additional restrictions may apply.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. CATEGORIES APIs and Bioactives > Arrhythmia, Beta Blockers